Vitamin D3 (cholecalciferol).

The hydroxylases that convert cholecalciferol to 25-hydroxyvitamin D and then to calcitriol are magnesium-dependent, as is the transport protein. Vitamin D cannot be activated without adequate magnesium.

Vitamin D raises osteocalcin and matrix Gla protein output, and MK-7 carboxylates them so they can bind calcium and direct where it goes. Without K2 the induced proteins remain inactive.

Any menaquinone feeds the gamma-carboxylase that activates the Gla proteins vitamin D produces. The pairing is the standard mineral routing partnership.

Calcitriol induces the TRPV6 channel and calbindin that carry calcium across the intestinal wall. Vitamin D status sets how much of a calcium dose is absorbed.

The vitamin D receptor binds DNA as a heterodimer with the retinoid X receptor, so retinoid supply is part of the signalling machinery. Very high retinol intakes can also compete for that shared partner.

The vitamin D receptor uses zinc finger domains to bind its response elements. Zinc is structural to the receptor rather than to the vitamin.

Cholecalciferol needs dietary lipid to form the micelles it is absorbed in. An oil carrier or a meal raises uptake compared with a dry dose alone.

An omega-3 oil base supplies the long-chain fat that carries cholecalciferol into micelles, which is why softgels are usually oil-filled. The effect is on absorption, not on activation.

Ergocalciferol competes with cholecalciferol for vitamin D binding protein and 25-hydroxylase while producing a shorter-lived metabolite. Combining the two forms can lower measured 25-hydroxyvitamin D3.

Vitamin K1 feeds the same carboxylase and is partly converted to menaquinone-4 in tissues. It covers the carboxylation of vitamin D-induced Gla proteins from a second form.

Boron influences how the body handles calcium, magnesium and vitamin D metabolites, and the two are often formulated together in bone-support blends. The human data are limited and mostly report changes in circulating markers rather than structural outcomes. Regard this as a mechanistic pairing with modest supporting work.

Cholecalciferol is fat-soluble and needs bile salts to form the mixed micelles that carry it across the intestinal wall. Anyone with reduced bile flow absorbs less of any given dose. Supplemental bile components are used in that context, and the relationship is textbook physiology rather than a trial finding.

Phospholipid emulsifiers disperse cholecalciferol into fine droplets, which is the same physical step that micelle formation performs in the gut. This is why oil and phospholipid carriers appear in D3 softgels and emulsions. It is a delivery relationship, not an added biological effect.

Phosphatidylcholine is the specific phospholipid that does most of the emulsifying work in lecithin-based carriers. Cholecalciferol partitions into that lipid phase and is presented to the intestine already dispersed. The pairing addresses solubility, which is the main practical limit on a fat-soluble vitamin taken without food.

Bicarbonate and cholecalciferol were examined in the same body of intervention work, on the reasoning that acid load and vitamin D status both bear on muscle and mineral handling. The combination has been studied, not established. This row records that the pairing exists in the literature.

Carotenoids and cholecalciferol both rely on the same mixed micelles for uptake, and a large dose of one fat-soluble compound can occupy micellar capacity that another would use. The practical size of this competition varies with dose and meal fat. Flagged as a competition to be aware of rather than a reason to separate them.

Tocopherols travel the same micellar and lipoprotein route as cholecalciferol, so very large tocopherol doses share the same transport capacity. In a softgel they also protect the carrier oil from oxidation. Both directions of the relationship are worth stating and neither is a reason to avoid the pair.

A triglyceride carrier keeps cholecalciferol in solution and triggers the bile release that absorption depends on. Taking D3 with a fat-containing meal does the same thing without any special formulation. This is the simplest lever on absorption and it costs nothing.

The active hormone form of vitamin D raises intestinal uptake of both calcium and phosphate, and the two minerals are deposited together in bone mineral. Phosphate handling is also fed back on by FGF23, which suppresses activation of vitamin D. The pair is inseparable in normal mineral physiology.